ArticleBone marrow transplantation2014
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial.
K E Herbert et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it